Cargando…

Contractile responses to ergotamine and dihydroergotamine in the perfused middle cerebral artery of rat

The vasomotor effects of ergotamine and dihydroergotamine (DHE) on the middle cerebral artery (MCA) of rats were studied using the pressurised arteriography method and in vitro myographs. MCAs from Sprague–Dawley rats were mounted on two glass micropipettes using the arteriograph, pressurised to 85...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tfelt-Hansen, Peer, Nilsson, Elisabeth, Edvinsson, Lars
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2007
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3476129/ https://www.ncbi.nlm.nih.gov/pubmed/17497262 http://dx.doi.org/10.1007/s10194-007-0368-9

Ejemplares similares

In silico screening of FDA approved drugs reveals ergotamine and dihydroergotamine as potential coronavirus main protease enzyme inhibitors
por: Gurung, Arun Bahadur, et al.
Publicado: (2020)

Differential inhibitory response to telcagepant on αCGRP induced vasorelaxation and intracellular Ca(2+) levels in the perfused and non-perfused isolated rat middle cerebral artery
por: Erdling, André, et al.
Publicado: (2017)

Ergotamine Induced Retroperitoneal Fibrosis
por: Patra, Susama, et al.
Publicado: (2021)

Contractile Response of Bovine Lateral Saphenous Vein to Ergotamine Tartrate Exposed to Different Concentrations of Molecularly Imprinted Polymer
por: Kudupoje, Manoj B., et al.
Publicado: (2018)

Dihydroergotamine Complicating Reversible Cerebral Vasoconstriction Syndrome in Status Migrainosus
por: Mullaguri, Naresh, et al.
Publicado: (2018)

Sumatriptan and dihydroergotamine in proximal and distal human isolated coronary arteries
por: Labruijere, S, et al.
Publicado: (2013)

Differential vasoactive effects of sildenafil and tadalafil on cerebral arteries –relevant to migraine?
por: Kruuse, Christina, et al.
Publicado: (2011)

Differential effects of selective PDE5 inhibitors in rat cerebral arteries in vitro and in vivo
por: Kruuse, Christina, et al.
Publicado: (2009)

Aprepitant for the management of nausea with inpatient IV dihydroergotamine
por: Chou, Denise E., et al.
Publicado: (2016)

Dihydroergotamine (DHE) – Then and Now: A Narrative Review
por: Silberstein, Stephen D., et al.
Publicado: (2019)

Ergotamine-Induced Upper Extremity Ischemia: A Case Report
por: Kim, Man Deuk, et al.
Publicado: (2005)

Ischemic Colitis Secondary to Ergotamine Use: A Case Study
por: Rodman, Regina E., et al.
Publicado: (2011)

Fremanezumab blocks CGRP induced dilatation in human cerebral, middle meningeal and abdominal arteries
por: Ohlsson, Lena, et al.
Publicado: (2018)

MAPK signaling pathway regulates cerebrovascular receptor expression in human cerebral arteries
por: Ansar, Saema, et al.
Publicado: (2013)

Optimized System for Cerebral Perfusion Monitoring in the Rat Stroke Model of Intraluminal Middle Cerebral Artery Occlusion
por: Beretta, Simone, et al.
Publicado: (2013)

Upper limb artery segmental occlusions due to chronic use of ergotamine combined with itraconazole, treated by thrombolysis
por: Cervi, Edoardo, et al.
Publicado: (2011)

Expression and Characterization of Purinergic Receptors in Rat Middle Meningeal Artery–Potential Role in Migraine
por: Haanes, Kristian Agmund, et al.
Publicado: (2014)

Inhibition of cerebrovascular raf activation attenuates cerebral blood flow and prevents upregulation of contractile receptors after subarachnoid hemorrhage
por: Ansar, Saema, et al.
Publicado: (2011)

Safety of domperidone in treating nausea associated with dihydroergotamine infusion and headache
por: Robbins, Nathaniel M., et al.
Publicado: (2016)

The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat
por: Maddahi, Aida, et al.
Publicado: (2011)

Neuropeptide release from slices of rat and guinea pig trigeminal ganglia: modulation by dihydroergotamine and sumatriptan
por: Tognetto, Michele, et al.
Publicado: (2000)

USE OF LOPINAVIR/RITONAVIR ASSOCIATED WITH ERGOTAMINE RESULTING IN FOOT AMPUTATION: BRIEF COMMUNICATION
por: Ferry, Fernando Raphael de Almeida, et al.
Publicado: (2014)

Human cerebrovascular contractile receptors are upregulated via a B-Raf/MEK/ERK-sensitive signaling pathway
por: Ahnstedt, Hilda, et al.
Publicado: (2011)

Drug-Drug Interaction of Ergotamine with a Combination of Darunavir, Abacavir, and Lamivudine Causing a Fatal Vasospastic Ischemia
por: Petit, Elisabeth, et al.
Publicado: (2018)

The role of α(1)- and α(2)-adrenoceptor subtypes in the vasopressor responses induced by dihydroergotamine in ritanserin-pretreated pithed rats
por: Rivera-Mancilla, Eduardo, et al.
Publicado: (2017)

Male-Female Differences in Upregulation of Vasoconstrictor Responses in Human Cerebral Arteries
por: Ahnstedt, Hilda, et al.
Publicado: (2013)

Computed tomography perfusion in detecting malignant middle cerebral artery infarct
por: Lee, Chun Lin, et al.
Publicado: (2019)

Effects of Early Rehydration on Brain Perfusion and Infarct Core after Middle Cerebral Artery Occlusion in Rats
por: Tsai, Yuan-Hsiung, et al.
Publicado: (2021)

Combination ergotamine and caffeine improves seated blood pressure and presyncopal symptoms in autonomic failure
por: Arnold, Amy C., et al.
Publicado: (2014)

Comparison of the vasodilator responses of isolated human and rat middle meningeal arteries to migraine related compounds
por: Grände, Gustaf, et al.
Publicado: (2014)

Altered Endothelin Receptor Expression and Affinity in Spontaneously Hypertensive Rat Cerebral and Coronary Arteries
por: Cao, Lei, et al.
Publicado: (2013)

Amylin: Localization, Effects on Cerebral Arteries and on Local Cerebral Blood Flow in the Cat
por: Edvinsson, Lars, et al.
Publicado: (2001)

Brachial Artery Vasospasm From Sequential Use of Intravenous Promethazine and Dihydroergotamine for Treatment of Status Migrainosus: A Case Report
por: Johns, Christopher, et al.
Publicado: (2023)

Lipid-soluble cigarette smoking particles induce expression of inflammatory and extracellular-matrix-related genes in rat cerebral arteries
por: Vikman, Petter, et al.
Publicado: (2009)

Ergot alkaloids: From witchcraft till in silico analysis. Multi-receptor analysis of ergotamine metabolites
por: Dellafiora, Luca, et al.
Publicado: (2015)

Effects of ergotamine on the central nervous system using untargeted metabolomics analysis in a mouse model
por: Reddy, Priyanka, et al.
Publicado: (2021)

A Rapid and Sensitive Stability-Indicating Eco-Friendly HPTLC Assay for Fluorescence Detection of Ergotamine
por: Shakeel, Faiyaz, et al.
Publicado: (2023)

Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations
por: Shafqat, Rafia, et al.
Publicado: (2020)

Dihydroergotamine and triptan use to treat migraine during pregnancy and the risk of adverse pregnancy outcomes
por: Bérard, Anick, et al.
Publicado: (2021)

Delivery of Dihydroergotamine Mesylate to the Upper Nasal Space for the Acute Treatment of Migraine: Technology in Action
por: Cooper, Wade, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_srj6lmeocjmf6a9kqdgosvup6a